Global Anti-Venom Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G1C1B31F20D3EN
QYResearch

Abstracts

This report focuses on the global Anti-Venom status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Venom development in North America, Europe, China and Japan.

The key players covered in this study

• CSL Behring
• Merck & Co.
• BTG Plc
• Pfizer
• Haffkine Bio-Pharmaceutical Corporation
• Rare Disease Therapeutics
• Flynn Pharma
• Vins Bioproducts
• Bharat Serums and Vaccines
• Serum Biotech

Market segment by Type, the product can be split into

• Polyvalent Antivenom
• Monovalent Antivenom

Market segment by Application, split into

• Retail Pharmacies
• Hospitals
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Anti-Venom status, future forecast, growth opportunity, key market and key players.
• To present the Anti-Venom development in North America, Europe, China and Japan.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anti-Venom are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Venom Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anti-Venom Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Polyvalent Antivenom
  1.4.3 Monovalent Antivenom
1.5 Market by Application
  1.5.1 Global Anti-Venom Market Share by Application: 2020 VS 2026
  1.5.2 Retail Pharmacies
  1.5.3 Hospitals
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anti-Venom Market Perspective (2015-2026)
2.2 Anti-Venom Growth Trends by Regions
  2.2.1 Anti-Venom Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anti-Venom Historic Market Share by Regions (2015-2020)
  2.2.3 Anti-Venom Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anti-Venom Market Growth Strategy
  2.3.6 Primary Interviews with Key Anti-Venom Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anti-Venom Players by Market Size
  3.1.1 Global Top Anti-Venom Players by Revenue (2015-2020)
  3.1.2 Global Anti-Venom Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anti-Venom Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Venom Market Concentration Ratio
  3.2.1 Global Anti-Venom Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anti-Venom Revenue in 2019
3.3 Anti-Venom Key Players Head office and Area Served
3.4 Key Players Anti-Venom Product Solution and Service
3.5 Date of Enter into Anti-Venom Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anti-Venom Historic Market Size by Type (2015-2020)
4.2 Global Anti-Venom Forecasted Market Size by Type (2021-2026)

5 ANTI-VENOM BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anti-Venom Market Size by Application (2015-2020)
5.2 Global Anti-Venom Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anti-Venom Market Size (2015-2020)
6.2 Anti-Venom Key Players in North America (2019-2020)
6.3 North America Anti-Venom Market Size by Type (2015-2020)
6.4 North America Anti-Venom Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anti-Venom Market Size (2015-2020)
7.2 Anti-Venom Key Players in Europe (2019-2020)
7.3 Europe Anti-Venom Market Size by Type (2015-2020)
7.4 Europe Anti-Venom Market Size by Application (2015-2020)

8 CHINA

8.1 China Anti-Venom Market Size (2015-2020)
8.2 Anti-Venom Key Players in China (2019-2020)
8.3 China Anti-Venom Market Size by Type (2015-2020)
8.4 China Anti-Venom Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anti-Venom Market Size (2015-2020)
9.2 Anti-Venom Key Players in Japan (2019-2020)
9.3 Japan Anti-Venom Market Size by Type (2015-2020)
9.4 Japan Anti-Venom Market Size by Application (2015-2020)

10 KEY PLAYERS PROFILES

10.1 CSL Behring
  10.1.1 CSL Behring Company Details
  10.1.2 CSL Behring Business Overview and Its Total Revenue
  10.1.3 CSL Behring Anti-Venom Introduction
  10.1.4 CSL Behring Revenue in Anti-Venom Business (2015-2020))
  10.1.5 CSL Behring Recent Development
10.2 Merck & Co.
  10.2.1 Merck & Co. Company Details
  10.2.2 Merck & Co. Business Overview and Its Total Revenue
  10.2.3 Merck & Co. Anti-Venom Introduction
  10.2.4 Merck & Co. Revenue in Anti-Venom Business (2015-2020)
  10.2.5 Merck & Co. Recent Development
10.3 BTG Plc
  10.3.1 BTG Plc Company Details
  10.3.2 BTG Plc Business Overview and Its Total Revenue
  10.3.3 BTG Plc Anti-Venom Introduction
  10.3.4 BTG Plc Revenue in Anti-Venom Business (2015-2020)
  10.3.5 BTG Plc Recent Development
10.4 Pfizer
  10.4.1 Pfizer Company Details
  10.4.2 Pfizer Business Overview and Its Total Revenue
  10.4.3 Pfizer Anti-Venom Introduction
  10.4.4 Pfizer Revenue in Anti-Venom Business (2015-2020)
  10.4.5 Pfizer Recent Development
10.5 Haffkine Bio-Pharmaceutical Corporation
  10.5.1 Haffkine Bio-Pharmaceutical Corporation Company Details
  10.5.2 Haffkine Bio-Pharmaceutical Corporation Business Overview and Its Total Revenue
  10.5.3 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Introduction
  10.5.4 Haffkine Bio-Pharmaceutical Corporation Revenue in Anti-Venom Business (2015-2020)
  10.5.5 Haffkine Bio-Pharmaceutical Corporation Recent Development
10.6 Rare Disease Therapeutics
  10.6.1 Rare Disease Therapeutics Company Details
  10.6.2 Rare Disease Therapeutics Business Overview and Its Total Revenue
  10.6.3 Rare Disease Therapeutics Anti-Venom Introduction
  10.6.4 Rare Disease Therapeutics Revenue in Anti-Venom Business (2015-2020)
  10.6.5 Rare Disease Therapeutics Recent Development
10.7 Flynn Pharma
  10.7.1 Flynn Pharma Company Details
  10.7.2 Flynn Pharma Business Overview and Its Total Revenue
  10.7.3 Flynn Pharma Anti-Venom Introduction
  10.7.4 Flynn Pharma Revenue in Anti-Venom Business (2015-2020)
  10.7.5 Flynn Pharma Recent Development
10.8 Vins Bioproducts
  10.8.1 Vins Bioproducts Company Details
  10.8.2 Vins Bioproducts Business Overview and Its Total Revenue
  10.8.3 Vins Bioproducts Anti-Venom Introduction
  10.8.4 Vins Bioproducts Revenue in Anti-Venom Business (2015-2020)
  10.8.5 Vins Bioproducts Recent Development
10.9 Bharat Serums and Vaccines
  10.9.1 Bharat Serums and Vaccines Company Details
  10.9.2 Bharat Serums and Vaccines Business Overview and Its Total Revenue
  10.9.3 Bharat Serums and Vaccines Anti-Venom Introduction
  10.9.4 Bharat Serums and Vaccines Revenue in Anti-Venom Business (2015-2020)
  10.9.5 Bharat Serums and Vaccines Recent Development
10.10 Serum Biotech
  10.10.1 Serum Biotech Company Details
  10.10.2 Serum Biotech Business Overview and Its Total Revenue
  10.10.3 Serum Biotech Anti-Venom Introduction
  10.10.4 Serum Biotech Revenue in Anti-Venom Business (2015-2020)
  10.10.5 Serum Biotech Recent Development

11 ANALYST'S VIEWPOINTS/CONCLUSIONS

12 APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anti-Venom Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Venom Revenue
Table 3. Ranking of Global Top Anti-Venom Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Venom Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Polyvalent Antivenom
Table 6. Key Players of Monovalent Antivenom
Table 7. Global Anti-Venom Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Anti-Venom Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Anti-Venom Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Anti-Venom Market Share by Regions (2015-2020)
Table 11. Global Anti-Venom Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Anti-Venom Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Anti-Venom Market Growth Strategy
Table 17. Main Points Interviewed from Key Anti-Venom Players
Table 18. Global Anti-Venom Revenue by Players (2015-2020) (Million US$)
Table 19. Global Anti-Venom Market Share by Players (2015-2020)
Table 20. Global Top Anti-Venom Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Venom as of 2019)
Table 21. Global Anti-Venom by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anti-Venom Product Solution and Service
Table 24. Date of Enter into Anti-Venom Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Venom Market Size by Type (2015-2020) (Million US$)
Table 27. Global Anti-Venom Market Size Share by Type (2015-2020)
Table 28. Global Anti-Venom Revenue Market Share by Type (2021-2026)
Table 29. Global Anti-Venom Market Size Share by Application (2015-2020)
Table 30. Global Anti-Venom Market Size by Application (2015-2020) (Million US$)
Table 31. Global Anti-Venom Market Size Share by Application (2021-2026)
Table 32. North America Key Players Anti-Venom Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Anti-Venom Market Share (2019-2020)
Table 34. North America Anti-Venom Market Size by Type (2015-2020) (Million US$)
Table 35. North America Anti-Venom Market Share by Type (2015-2020)
Table 36. North America Anti-Venom Market Size by Application (2015-2020) (Million US$)
Table 37. North America Anti-Venom Market Share by Application (2015-2020)
Table 38. Europe Key Players Anti-Venom Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Anti-Venom Market Share (2019-2020)
Table 40. Europe Anti-Venom Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Anti-Venom Market Share by Type (2015-2020)
Table 42. Europe Anti-Venom Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Anti-Venom Market Share by Application (2015-2020)
Table 44. China Key Players Anti-Venom Revenue (2019-2020) (Million US$)
Table 45. China Key Players Anti-Venom Market Share (2019-2020)
Table 46. China Anti-Venom Market Size by Type (2015-2020) (Million US$)
Table 47. China Anti-Venom Market Share by Type (2015-2020)
Table 48. China Anti-Venom Market Size by Application (2015-2020) (Million US$)
Table 49. China Anti-Venom Market Share by Application (2015-2020)
Table 50. Japan Key Players Anti-Venom Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Anti-Venom Market Share (2019-2020)
Table 52. Japan Anti-Venom Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Anti-Venom Market Share by Type (2015-2020)
Table 54. Japan Anti-Venom Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Anti-Venom Market Share by Application (2015-2020)
Table 56. CSL Behring Company Details
Table 57. CSL Behring Business Overview
Table 58. CSL Behring Product
Table 59. CSL Behring Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 60. CSL Behring Recent Development
Table 61. Merck & Co. Company Details
Table 62. Merck & Co. Business Overview
Table 63. Merck & Co. Product
Table 64. Merck & Co. Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 65. Merck & Co. Recent Development
Table 66. BTG Plc Company Details
Table 67. BTG Plc Business Overview
Table 68. BTG Plc Product
Table 69. BTG Plc Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 70. BTG Plc Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Product
Table 74. Pfizer Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 75. Pfizer Recent Development
Table 76. Haffkine Bio-Pharmaceutical Corporation Company Details
Table 77. Haffkine Bio-Pharmaceutical Corporation Business Overview
Table 78. Haffkine Bio-Pharmaceutical Corporation Product
Table 79. Haffkine Bio-Pharmaceutical Corporation Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 80. Haffkine Bio-Pharmaceutical Corporation Recent Development
Table 81. Rare Disease Therapeutics Company Details
Table 82. Rare Disease Therapeutics Business Overview
Table 83. Rare Disease Therapeutics Product
Table 84. Rare Disease Therapeutics Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 85. Rare Disease Therapeutics Recent Development
Table 86. Flynn Pharma Company Details
Table 87. Flynn Pharma Business Overview
Table 88. Flynn Pharma Product
Table 89. Flynn Pharma Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 90. Flynn Pharma Recent Development
Table 91. Vins Bioproducts Business Overview
Table 92. Vins Bioproducts Product
Table 93. Vins Bioproducts Company Details
Table 94. Vins Bioproducts Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 95. Vins Bioproducts Recent Development
Table 96. Bharat Serums and Vaccines Company Details
Table 97. Bharat Serums and Vaccines Business Overview
Table 98. Bharat Serums and Vaccines Product
Table 99. Bharat Serums and Vaccines Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 100. Bharat Serums and Vaccines Recent Development
Table 101. Serum Biotech Company Details
Table 102. Serum Biotech Business Overview
Table 103. Serum Biotech Product
Table 104. Serum Biotech Revenue in Anti-Venom Business (2015-2020) (Million US$)
Table 105. Serum Biotech Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anti-Venom Market Share by Type: 2020 VS 2026
Figure 2. Polyvalent Antivenom Features
Figure 3. Monovalent Antivenom Features
Figure 4. Global Anti-Venom Market Share by Application: 2020 VS 2026
Figure 5. Retail Pharmacies Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Anti-Venom Report Years Considered
Figure 9. Global Anti-Venom Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Anti-Venom Market Share by Regions: 2020 VS 2026
Figure 11. Global Anti-Venom Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Anti-Venom Market Share by Players in 2019
Figure 14. Global Top Anti-Venom Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Venom as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Anti-Venom Revenue in 2019
Figure 16. North America Anti-Venom Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Anti-Venom Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Anti-Venom Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Anti-Venom Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. CSL Behring Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 22. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Merck & Co. Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 24. BTG Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. BTG Plc Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 28. Haffkine Bio-Pharmaceutical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Haffkine Bio-Pharmaceutical Corporation Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 30. Rare Disease Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Rare Disease Therapeutics Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 32. Flynn Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Flynn Pharma Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 34. Vins Bioproducts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Vins Bioproducts Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 36. Bharat Serums and Vaccines Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bharat Serums and Vaccines Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 38. Serum Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Serum Biotech Revenue Growth Rate in Anti-Venom Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed